A Rare Presentation of Drug-induced Liver Injury with Fluticasone and Vilanterol Inhaler Use

Mohit Rishi; Amanda Wagner; Mark Ulanja; Bryce D Beutler; Karmjit Singh

doi:10.7759/cureus.4933

A Rare Presentation of Drug-induced Liver Injury with Fluticasone and Vilanterol Inhaler Use

Cureus. 2019 Jun 18;11(6):e4933. doi: 10.7759/cureus.4933.

Authors

Mohit Rishi¹, Amanda Wagner², Mark Ulanja¹, Bryce D Beutler¹, Karmjit Singh³

Affiliations

¹ Internal Medicine, University of Nevada, Reno School of Medicine, Reno, USA.
² Family Medicine, University of Nevada, Reno School of Medicine, Reno, USA.
³ Internal Medicine, Aureus University School of Medicine, Oranjestad, ABW.

Abstract

Drug-induced liver injury (DILI) is a rare and potentially lethal condition associated with the use of many commonly-used medications, including inhaled fluticasone-vilanterol. Therefore, a careful review of medications should always be obtained in the setting of acute onset hepatic dysfunction. We present the first reported case of idiosyncratic drug-induced liver injury associated with the use of this medication.

Keywords: breo ellipta; dili; drug induced liver injury; idiosyncratic.

Publication types

Case Reports